MitoChem Therapeutics is Biotechnology in United States that focus on related macular degeneration business. Founded in 2010. They cover business area such as developer, treatment, mitochondrial dysfunction, neurodegenerative disease, retinitis pigmentosa, age-relate macular degeneration, glaucoma.
2010
( 14 years old in 2024 )
Related Macular Degeneration
-
645 Meeting Street
Suite 11
Charleston, SC 29403
United States
Private
developertreatmentmitochondrial dysfunctionneurodegenerative diseaseretinitis pigmentosaage-relate macular degenerationglaucoma
* We use standard office opening hours in near MitoChem Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MitoChem Therapeutics is Biotechnology business from United States that founded in 2010 (14 years old in 2024), MitoChem Therapeutics business is focusing on Related Macular Degeneration.
MitoChem Therapeutics headquarter office and corporate office address is located in 645 Meeting Street Suite 11 Charleston, SC 29403 United States.
MitoChem Therapeutics was founded in United States.
In 2024, MitoChem Therapeutics is currently focus on related macular degeneration sector.
Above is snippet of Google Trends for "related macular degeneration" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MitoChem Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
